Chapter 31 Red cell isoimmunisation
Perinatal mortality rate
Perinatal mortality due to Rhesus D (RhD) isoimmunisation before the use of prophylaxis was 15 in 1000, or 4% of perinatal deaths. Today, the perinatal mortality rate from RhD isoimmunisation is 0.54 in 10,000, or 0.3%. The reduced perinatal mortality is due to anti-D immunoglobulin prophylaxis and the fall in numbers of large families.
Prevention of RhD isoimmunisation
Antenatal management of Rhesus isoimmunisation
Determination of fetal Rhesus type
Antibody quantification
Assessment of the fetal anaemia
Fetal blood sampling
Other red cell antibodies
Anti-Kell
Over 90% of the population is Kell-negative. Most Kell antibodies develop because of incompatible transfusion. There appears to be a poor correlation between the antibody titre and the effect on the fetus or neonate. Anti-Kell severity can change rapidly due to the antibodies’ ability to suppress erythropoiesis. Ultrasound assessment of fetal liver size is useful.
Moise K.J. The usefulness of middle cerebral artery Doppler assessment in the treatment of the fetus at risk for anemia. American Journal of Obstetrics and Gynecology. 2008;198:161.
Oepekes D., Seaward P.G., Frank P.H.A., et al. Doppler ultrasonography versus amniocentesis to predict fetal anemia. New England Journal of Medicine. 2006;355:156-164.